192 related articles for article (PubMed ID: 24039540)
1. Modeling of nanotherapeutics delivery based on tumor perfusion.
van de Ven AL; Abdollahi B; Martinez CJ; Burey LA; Landis MD; Chang JC; Ferrari M; Frieboes HB
New J Phys; 2013 May; 15():55004. PubMed ID: 24039540
[TBL] [Abstract][Full Text] [Related]
2. Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors.
van de Ven AL; Wu M; Lowengrub J; McDougall SR; Chaplain MA; Cristini V; Ferrari M; Frieboes HB
AIP Adv; 2012 Mar; 2(1):11208. PubMed ID: 22489278
[TBL] [Abstract][Full Text] [Related]
3. Smart Nanotherapeutic Targeting of Tumor Vasculature.
Li Z; Di C; Li S; Yang X; Nie G
Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
[TBL] [Abstract][Full Text] [Related]
4. Intravital microscopy for evaluating tumor perfusion of nanoparticles exposed to non-invasive radiofrequency electric fields.
Lapin NA; Krzykawska-Serda M; Ware MJ; Curley SA; Corr SJ
Cancer Nanotechnol; 2016; 7():5. PubMed ID: 27429662
[TBL] [Abstract][Full Text] [Related]
5. Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy.
Kai M; Ziemys A; Liu YT; Kojic M; Ferrari M; Yokoi K
Transl Oncol; 2019 Sep; 12(9):1196-1205. PubMed ID: 31228770
[TBL] [Abstract][Full Text] [Related]
6. Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice.
Zhang B; Jiang T; She X; Shen S; Wang S; Deng J; Shi W; Mei H; Hu Y; Pang Z; Jiang X
Biomaterials; 2016 Jul; 96():63-71. PubMed ID: 27149664
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice.
Zhang B; Jin K; Jiang T; Wang L; Shen S; Luo Z; Tuo Y; Liu X; Hu Y; Pang Z
Sci Rep; 2017 Aug; 7(1):10071. PubMed ID: 28855534
[TBL] [Abstract][Full Text] [Related]
8. Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy.
Wang Z
Theranostics; 2016; 6(13):2431-2438. PubMed ID: 27877245
[TBL] [Abstract][Full Text] [Related]
9. Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.
Chu D; Dong X; Zhao Q; Gu J; Wang Z
Adv Mater; 2017 Jul; 29(27):. PubMed ID: 28504320
[TBL] [Abstract][Full Text] [Related]
10. Multistage nanoparticles for improved delivery into tumor tissue.
Stylianopoulos T; Wong C; Bawendi MG; Jain RK; Fukumura D
Methods Enzymol; 2012; 508():109-30. PubMed ID: 22449923
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors.
Naumenko V; Nikitin A; Garanina A; Melnikov P; Vodopyanov S; Kapitanova K; Potashnikova D; Vishnevskiy D; Alieva I; Ilyasov A; Eletskaya BZ; Abakumov M; Chekhonin V; Majouga A
Acta Biomater; 2020 Mar; 104():176-187. PubMed ID: 31945505
[TBL] [Abstract][Full Text] [Related]
12. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer.
Zhang B; Jiang T; Shen S; She X; Tuo Y; Hu Y; Pang Z; Jiang X
Biomaterials; 2016 Oct; 103():12-21. PubMed ID: 27376555
[TBL] [Abstract][Full Text] [Related]
13. Multistage nanoparticle delivery system for deep penetration into tumor tissue.
Wong C; Stylianopoulos T; Cui J; Martin J; Chauhan VP; Jiang W; Popovic Z; Jain RK; Bawendi MG; Fukumura D
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2426-31. PubMed ID: 21245339
[TBL] [Abstract][Full Text] [Related]
14. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
[TBL] [Abstract][Full Text] [Related]
15. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia.
Li L; ten Hagen TL; Bolkestein M; Gasselhuber A; Yatvin J; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Apr; 167(2):130-7. PubMed ID: 23391444
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced changes in microcirculation and interstitial fluid pressure affecting the delivery of macromolecules and nanotherapeutics to tumors.
Multhoff G; Vaupel P
Front Oncol; 2012; 2():165. PubMed ID: 23162794
[TBL] [Abstract][Full Text] [Related]
17. Effects of lung ventilation-perfusion and muscle metabolism-perfusion heterogeneities on maximal O2 transport and utilization.
Cano I; Roca J; Wagner PD
J Physiol; 2015 Apr; 593(8):1841-56. PubMed ID: 25640017
[TBL] [Abstract][Full Text] [Related]
18. Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy.
Hak S; Cebulla J; Huuse EM; Davies Cde L; Mulder WJ; Larsson HB; Haraldseth O
Angiogenesis; 2014 Jan; 17(1):93-107. PubMed ID: 23982332
[TBL] [Abstract][Full Text] [Related]
19. Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Blanco E; Shen H; Ferrari M
Nat Biotechnol; 2015 Sep; 33(9):941-51. PubMed ID: 26348965
[TBL] [Abstract][Full Text] [Related]
20. Intravital Monitoring of Vasculature After Targeted Gene Therapy Alone or Combined With Tumor Irradiation.
Savarin M; Prevc A; Rzek M; Bosnjak M; Vojvodic I; Cemazar M; Jarm T; Sersa G
Technol Cancer Res Treat; 2018 Jan; 17():1533033818784208. PubMed ID: 29969947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
